NEWS
Hidde Elferink receives PhD degree cum laude
May 2021
On May 20, Hidde Elferink received his PhD degree cum laude. We congratulate him with his excellent thesis and defence. He showed to be able to cover many different aspects on glycosyl cations in an outstanding way.
Part of his work in the Thomas Boltje Research Group at the Radboud University involved a collaboration with PharmaCytics. These research efforts culminated into a patent. We keep working with the Boltje group on these topics.
Hidde Elferink completes doctoral thesis
May 2021
As PharmaCytics we would like to congratulate Hidde Elferink with completion of his doctoral thesis on “Exploring Glycosyl Cations”. Part of the study was done in a collaboration between the Radboud University and PharmaCytics.
We would like to express our gratitude to Hidde and his supervisor Thomas Boltje for the pleasant collaboration and for their contribution to the work of PharmaCytics.
We wish Hidde good luck with the public defense of his thesis on May 20th 2021 and all the best in his future career.
PHARMACYTICS TO BE SELECTED FOR THE EIT HEALTH GOLD TRACK
January 2021
PHARMACYTICS LAUNCHES NEW LOGO
October 2020
PharmaCytics has launched a new logo and a new corporate design!
PHARMACYTICS WINS INNOVATIONS FOR HEALTH 2020 AWARD
February 2020
PharmaCytics has won the Innovation for Health & Global Investor Forum award 2020. PharmaCytics got the popular vote as well as a unanimous vote from the Jury, consisting of investors. For PharmaCytics this is an important step in recognition of the value of our Technology that can turn parenteral drugs into an oral variant by making them look like nutrients.